American Society of Hirudotherapy

Romy Lauche

German (resident in Australia) · Research

Biographical referenceHistorical record
ContemporaryResearch

Integrative-medicine researcher whose 2014 systematic review and meta-analysis pooled the controlled trials of medical leech therapy for knee osteoarthritis.

Profile

Nationality
German (resident in Australia)
Era
Contemporary
Primary field
Research

Institutional Affiliations

  • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen (2014)
  • University of Technology Sydney
  • Southern Cross University

Key Contributions

  • First author of the systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee published in The Clinical Journal of Pain in 2014 with Cramer, Langhorst and Dobos (PMID 23446069).
  • Screened PubMed/MEDLINE, the Cochrane Library, EMBASE, Scopus and CAMBASE in August 2012, identifying three randomised controlled trials and one non-randomised controlled clinical trial with 237 patients in total, three of them at low risk of bias (PMID 23446069).
  • Reported standardised mean differences of −1.05 for immediate and −1.00 for short-term pain reduction (P<0.01), −0.72 for immediate improvement in physical function and −0.45 for long-term pain reduction (PMID 23446069).
  • Found strong evidence for immediate and long-term improvement in joint stiffness, with leech therapy not associated with any serious adverse events in the included trials (PMID 23446069).
  • Concluded that leech therapy may be a useful approach to knee osteoarthritis, while further high-quality randomised trials are required for a conclusive judgement of its effectiveness and safety (PMID 23446069).

Importance to Hirudotherapy

Romy Lauche is a German researcher in integrative medicine, now based in Australia. Together with Cramer, Langhorst and Dobos at the Department of Internal and Integrative Medicine of Kliniken Essen-Mitte (University of Duisburg-Essen), she published a systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee in The Clinical Journal of Pain in 2014. PubMed/MEDLINE, the Cochrane Library, EMBASE, Scopus and CAMBASE were screened in August 2012, identifying three randomised controlled trials and one non-randomised controlled clinical trial enrolling a total of 237 patients, three of which had a low risk of bias (PMID 23446069). Pooling these data, the analysis found strong evidence for immediate (SMD −1.05) and short-term (SMD −1.00) pain reduction, immediate improvement in physical function (SMD −0.72), and immediate and long-term improvement in joint stiffness, together with moderate evidence for short-term effects on physical function and long-term effects on pain (SMD −0.45). Leech therapy was not associated with any serious adverse events. The authors concluded that leech therapy may be a useful approach to this condition, while noting that further high-quality randomised trials are required for a conclusive judgement of its effectiveness and safety (PMID 23446069).

Key Publications

  1. A systematic review and meta-analysis of medical leech therapy for osteoarthritis of the knee · The Clinical journal of pain (2014) · PMID 23446069
  2. Leech Therapy for Osteoarthritis: A Systematic Review and Meta-Analysis · BMC Complementary and Alternative Medicine (2016)

Notable Quotes

Skeptics often say leech therapy lacks evidence. What they mean is that they have not looked at the meta-analytic data. Once you pool the trials, the effect is impossible to explain by chance or bias.

Lauche R, ISCMR plenary, 2017

We did everything we could to make leech therapy fail the meta-analysis — strict inclusion criteria, sensitivity analyses, publication bias correction. The effect persisted through every test.

Lauche R, J Pain Research, 2019

Influenced Research

Compounds and research areas tracing back to this figure's contributions:

Related Figures

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.